Acrivon Therapeutics, Inc. (ACRV)

NASDAQ: ACRV · IEX Real-Time Price · USD
12.50
-0.35 (-2.72%)
At close: Dec 1, 2022 4:00 PM
12.70
+0.20 (1.60%)
After-hours: Dec 1, 2022 6:25 PM EST

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 20212020
Selling, General & Admin
2.471.3
Research & Development
13.721.87
Operating Expenses
16.183.17
Operating Income
-16.18-3.17
Other Expense / Income
0.062.14
Pretax Income
-16.24-5.31
Net Income
-16.24-5.31
Net Income Common
-16.24-5.31
Shares Outstanding (Basic)
44
Shares Outstanding (Diluted)
44
Shares Change
21.70%-
EPS (Basic)
-3.78-1.50
EPS (Diluted)
-3.78-1.50
Free Cash Flow Per Share
-3.31-0.80
EBITDA
-15.41-5.29
Depreciation & Amortization
0.830.01
EBIT
-16.24-5.31
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).